{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:24:07Z","timestamp":1773455047439,"version":"3.50.1"},"reference-count":34,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Purpose: Graft failure after penetrating keratoplasty (PK) is a serious complication, especially in eyes with herpetic keratitis (HK). This study evaluated the prevalence and graft survival of herpes simplex virus type 1 (HSV-1) and varicella zoster virus (VZV) DNA in recipient corneas during PK. Methods: The retrospective study was performed at the Department of Ophthalmology at University Hospital in Mainz, Germany. We analyzed data from every patient who underwent PK between January 2020 and June 2021. According to our clinical routine, we performed HSV-1 and VZV polymerase chain reaction (PCR) on all excised corneal buttons regardless of the primary clinical diagnosis. Results: We included 112 eyes of 112 consecutive patients who underwent PK. At the time of PK, 91 (81.25%) patients had no history of HK and 21 (18.75%) patients did. The recipient corneas of 91 patients without a history of HK tested positive for HSV-1 DNA in 12 (13.2%) eyes, for VZV DNA in 3 (3.3%) eyes, and for HSV-1 and VZV DNA simultaneously in 2 (2.2%) eyes. The recipient corneas of 21 patients with a preoperative history of HK tested positive for HSV-1 DNA in 13 (61.9%) eyes and VZV DNA in 1 (4.8%) eye. All patients with positive herpes DNA and no history of HK prior to PK received antiherpetic treatment and had a 100% graft survival rate after 1 year. Conclusions: We found herpesvirus DNA in 18.7% of recipient corneas without clinical suspicion or history of herpes keratitis. This suggests the need of routine HSV-1 and VZV PCR testing in all explanted corneas regardless of clinical suspicion, to detect, treat and prevent possible recurrence of herpes infection in corneal grafts and support graft survival.<\/jats:p>","DOI":"10.3390\/jcm12010289","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T03:18:18Z","timestamp":1672370298000},"page":"289","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prevalence of Herpesvirus DNA in Corneal Transplant Recipients"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-5787","authenticated-orcid":false,"given":"Julia Bing","family":"Bu","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie D.","family":"Grabitz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7025-8280","authenticated-orcid":false,"given":"Joanna","family":"Wasielica-Poslednik","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00003226-199903000-00001","article-title":"Classification of herpes simplex virus keratitis and anterior uveitis","volume":"18","author":"Liesegang","year":"1999","journal-title":"Cornea"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/599329","article-title":"Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues","volume":"200","author":"Remeijer","year":"2009","journal-title":"J. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0022-510X(93)90082-A","article-title":"Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue","volume":"116","author":"Liedtke","year":"1993","journal-title":"J. Neurol. Sci"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJM198603133141105","article-title":"Infections with herpes simplex viruses","volume":"314","author":"Corey","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_5","unstructured":"Minor, M., and Payne, E. (2021). Herpes Zoster Ophthalmicus, StatPearls Publishing."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/s-0035-1545975","article-title":"The Chameleon of Herpetic Keratitis\u2014Diagnosis and Therapy","volume":"232","author":"Seitz","year":"2015","journal-title":"Klin. Monbl. Augenheilkd."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1136\/bjo.2003.031948","article-title":"Penetrating keratoplasty: Indications over a 10 year period","volume":"88","author":"Mavrikakis","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.survophthal.2007.04.008","article-title":"Corneal graft rejection","volume":"52","author":"Panda","year":"2007","journal-title":"Surv. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.86.6.646","article-title":"The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin","volume":"86","author":"Halberstadt","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/eye.2010.237","article-title":"Antiviral treatment following penetrating keratoplasty for herpetic keratitis","volume":"25","author":"Goodfellow","year":"2011","journal-title":"Eye"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/eye.1988.73","article-title":"Longterm prognosis for corneal grafting in herpes simplex keratitis","volume":"2","author":"Ficker","year":"1988","journal-title":"Eye"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/ICO.0b013e31802eaee6","article-title":"Corneal buttons obtained from patients with HSK harbor high copy numbers of the HSV genome","volume":"26","author":"Shimomura","year":"2007","journal-title":"Cornea"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2007.10.005","article-title":"Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty","volume":"145","author":"Ghosh","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00154385","article-title":"Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis","volume":"80","author":"Foster","year":"1992","journal-title":"Doc. Ophthalmol."},{"key":"ref_15","first-page":"1710","article-title":"Long-term outcomes of penetrating keratoplasty for corneal complications of herpes zoster ophthalmicus","volume":"103","author":"Tanaka","year":"2019","journal-title":"Br. J. Ophthalmol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jfma.2019.12.009","article-title":"The presence and impact of herpes virus DNA in recipient cornea and aqueous humor on graft survival following penetrating keratoplasty","volume":"119","author":"Jeng","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bjo.84.6.563","article-title":"Human herpesviruses in the cornea","volume":"84","author":"Kaye","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"ref_18","first-page":"1847","article-title":"Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits","volume":"39","author":"Tsao","year":"1998","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_19","first-page":"e77","article-title":"Herpes simplex virus PCR in 2230 explanted corneal buttons","volume":"100","author":"Seitz","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bjo.84.11.1238","article-title":"Detection of herpes simplex virus type 1, 2 and varicella zoster virus DNA in recipient corneal buttons","volume":"84","author":"Treffers","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1086\/342966","article-title":"Valacyclovir for herpes simplex virus infection: Long-term safety and sustained efficacy after 20 years\u2019 experience with acyclovir","volume":"186","author":"Tyring","year":"2002","journal-title":"J. Infect. Dis"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/092739490500363","article-title":"Human herpes simplex virus keratitis: The pathogenesis revisited","volume":"12","author":"Remeijer","year":"2004","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_23","first-page":"CD007824","article-title":"Oral antivirals for preventing recurrent herpes simplex keratitis in people with corneal grafts","volume":"11","author":"Bhatt","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1001\/archopht.1997.01100150592003","article-title":"Detection of varicella-zoster virus DNA in keratectomy specimens by use of the polymerase chain reaction","volume":"115","author":"Mietz","year":"1997","journal-title":"Arch. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00003226-199303000-00007","article-title":"Detection of varicella zoster virus DNA and viral antigen in human cornea after herpes zoster ophthalmicus","volume":"12","author":"Wenkel","year":"1993","journal-title":"Cornea"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0161-6420(00)00115-9","article-title":"Anterior uveitis with sectoral iris atrophy in the absence of keratitis: A distinct clinical entity among herpetic eye diseases","volume":"107","author":"Ooijman","year":"2000","journal-title":"Ophthalmology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1007\/s00417-020-04984-2","article-title":"The incidence and influence of the donor corneas positive for herpesviridae DNA in keratoplasty","volume":"258","author":"Qu","year":"2020","journal-title":"Graefe\u2019s Arch. Clin. Exp. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0140-6736(00)04011-3","article-title":"Herpes simplex virus 1 transmission through corneal transplantation","volume":"357","author":"Remeijer","year":"2001","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00347-012-2569-0","article-title":"Ping-pong transmission of herpes simplex virus 1 following corneal transplantation","volume":"109","author":"Stavridis","year":"2012","journal-title":"Ophthalmologe"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1097\/01.ico.0000263126.76392.cf","article-title":"Reactivation and Donor-Host Transmission of Herpes Simplex Virus After Corneal Transplantation","volume":"21","author":"Zheng","year":"2002","journal-title":"Cornea"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00003226-199405000-00007","article-title":"A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis","volume":"13","author":"Barney","year":"1994","journal-title":"Cornea"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.117.4.445","article-title":"Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis","volume":"117","author":"Tambasco","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/ICU.0000000000000482","article-title":"Herpetic eye disease study: Lessons learned","volume":"29","author":"Kalezic","year":"2018","journal-title":"Curr. Opin. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2217\/fmb.11.73","article-title":"Ocular herpes simplex virus: How are latency, reactivation, recurrent disease and therapy interrelated?","volume":"6","author":"Clerkin","year":"2011","journal-title":"Futur. Microbiol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/1\/289\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:55:59Z","timestamp":1760147759000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/1\/289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["jcm12010289"],"URL":"https:\/\/doi.org\/10.3390\/jcm12010289","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}